Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Advisory Panel Appointment

2 Sep 2019 09:29

RNS Number : 8648K
Location Sciences Group PLC
02 September 2019
 

2 September 2019

Location Sciences Group PLC

("Location Sciences" or the "Company")

Advisory Panel Appointment

 

Location Sciences appoints Michael Iantosca to join its Advisory Panel

 

Location Sciences (AIM: LSAI), the leading location data verification and analytics company, announces the appointment of Michael Iantosca to its Advisory Panel. Michael will advise the Company on its US growth strategy.

 

Michael spent the past seven years as Chief Revenue Officer at Integral Ad Science ("IAS"), a leading verification company in the digital advertising industry. Prior to IAS, Michael served as the Vice President of Ad Sales for VEVO, the world's leading all-premium music video and entertainment platform.

 

Michael's extensive experience in generating revenues will help with Location Sciences' commercial drive, which the Board believes will deliver substantial value for investors.

 

Mark Slade, Chief Executive Officer of Location Sciences, commented: "We are extremely pleased to welcome Michael to join our advisory team. His experience in growing a verification business in the US will be a huge asset to us as we grow our US business."

 

Michael Iantosca commented: "Brands and marketers are seeking new ways to optimise their campaign performance with transparency and trust. Verify - Location Sciences' independent location verification platform - has the potential to transform the way location advertising works. That's why the business has attracted an industry-leading Advisory Board; all committed to bringing greater integrity to the location data marketplace."

 

For further information please contact:

 

Location Sciences Group PLC

via Milk and Honey PR

Mark Slade, Chief Executive Officer

David Rae, Chief Financial Officer

Shore Capital (Nominated Adviser and Broker)

Tel: +44 (0)20 7408 4090

 

Tom Griffiths / David Coaten

 

Milk & Honey PR

 

Tel: +44 (0)20 3637 7310

Kirsty Leighton

Jessica Ballinger

 

About Location Sciences Group PLC:

Location Sciences is the pre-eminent global location verification provider to the $160 billion digital advertising industry. Working in partnership with brands, media agencies and suppliers to reduce ad-wastage and improve the effectiveness of location-based advertising campaigns.

The digital advertising marketplace remains unregulated and un-monitored, with an estimated $19 billion wasted on ad-fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies Verify detects location ad-fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the marketplace.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSSWSAEFUSEEU
Date   Source Headline
11th May 20219:05 amRNSSecond Price Monitoring Extn
11th May 20219:00 amRNSPrice Monitoring Extension
6th May 20217:00 amRNSResult of Broker Option
5th May 20212:06 pmRNSSecond Price Monitoring Extn
5th May 20212:00 pmRNSPrice Monitoring Extension
4th May 202111:05 amRNSSecond Price Monitoring Extn
4th May 202111:00 amRNSPrice Monitoring Extension
4th May 20219:05 amRNSSecond Price Monitoring Extn
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:00 amRNSProposed Fundraise of up to £3.85m - Notice of GM
23rd Apr 20212:05 pmRNSSecond Price Monitoring Extn
23rd Apr 20212:00 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSFinal Results for the year ended 31 December 2020
15th Mar 20214:41 pmRNSSecond Price Monitoring Extn
15th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 202111:00 amRNSPrice Monitoring Extension
19th Feb 20213:36 pmRNSTR-1 Notification of major holdings
11th Feb 202111:06 amRNSSecond Price Monitoring Extn
11th Feb 202111:00 amRNSPrice Monitoring Extension
11th Feb 20219:05 amRNSSecond Price Monitoring Extn
11th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSTrading Update and Directorate Changes
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:36 pmRNSPrice Monitoring Extension
20th Jan 20214:40 pmRNSSecond Price Monitoring Extn
20th Jan 20214:35 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSHolding(s) in Company
17th Dec 20204:41 pmRNSSecond Price Monitoring Extn
17th Dec 20204:35 pmRNSPrice Monitoring Extension
16th Dec 20204:41 pmRNSSecond Price Monitoring Extn
16th Dec 20204:36 pmRNSPrice Monitoring Extension
14th Dec 20207:00 amRNSPotential Defamation Action Against the Company
30th Nov 20207:00 amRNSNew Contract Win and Trading Update
5th Nov 20203:44 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSIssue of shares to directors in lieu of fees & TVR
1st Oct 20207:00 amRNSAppointment of Nominated Adviser
17th Sep 202012:43 pmRNSHalf-year Report - Replacement
15th Sep 20207:00 amRNSHalf-year Report
1st Sep 20209:05 amRNSSecond Price Monitoring Extn
1st Sep 20209:00 amRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSContract
27th Jul 20207:00 amRNSTrading Update
3rd Jul 202011:05 amRNSSecond Price Monitoring Extn
3rd Jul 202011:00 amRNSPrice Monitoring Extension
1st Jul 202010:02 amRNSIssue of Equity and Total Voting Rights
16th Jun 202010:36 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.